Amphastar Prescription drugs, Inc. (AMPH) Barclays twenty eighth Annual World Healthcare Convention March 10, 2026 8:00 PM EDT
Firm Contributors
William Peters – CFO, Govt VP of Finance, Treasurer & Director
Dan Dischner – Senior Vice President of Human Assets & Company Communication
Convention Name Contributors
Glen Santangelo – Barclays Financial institution PLC, Analysis Division
Presentation
Glen Santangelo
Barclays Financial institution PLC, Analysis Division
All proper. Properly, thanks. Good afternoon, everyone. Thanks for becoming a member of us. We’re very excited to be internet hosting Amphastar Prescription drugs. To my proper is Invoice Peters, the CFO; and to his proper is Dan Dischner, who’s in command of the Company Communications and another issues at Amphastar.
For these of you who do not know me, I will introduce myself. I am Glen Santangelo. I am the analyst at Barclays that covers the spec pharma and animal well being house, amongst another issues. And we’re excited to have you ever each right here right now. So thanks for becoming a member of us.
William Peters
CFO, Govt VP of Finance, Treasurer & Director
Thanks for having us.
Dan Dischner
Senior Vice President of Human Assets & Company Communication
thanks for having us.
Query-and-Reply Session
Glen Santangelo
Barclays Financial institution PLC, Analysis Division
All proper. Properly, why do not we simply type of dive proper into it. Invoice, I feel an incredible place to start out goes to be speaking about a few of the highlights from the fourth quarter and actually fiscal ’25, perhaps extra broadly. Clearly, there have been some positives within the 12 months that I feel we will focus on. However to be balanced, I feel perhaps even within the fourth quarter, there are a few merchandise that perhaps fell a bit bit wanting your expectations. And so why do not you perhaps to degree set us, simply put all that in perspective after which we will type of dive proper in. And as a part of that, I do not know there, you may emphasize perhaps some